INNOVATIVE CANCER CARE
About Verthermia®
At Verthermia®, our mission is to extend and enhance life for people with advanced unresponsive cancer. We also pledge to continue investigating how our natural process can fight deadly diseases and viruses, in addition to cancer treatment.
Speak With Heatt Experts:
Call us today
OVERSEEING OPERATIONS
Our Management Team
Verthermia’s management team is responsible for overseeing all medical operations and ensuring that our treatment protocols are in line with the latest advancements in the field. Our team is composed of professionals from the medical and business worlds. Working in tandem with our staff of highly trained professionals, our management team provides the foundation for Verthermia’s operational and medical efficiency.
JOSEPH (JAY) ZWISCHENBERGER, M.D.CHIEF MEDICAL OFFICER, CARDIOTHORACIC SURGEON, CRITICAL CAREDr. Zwischenberger serves at the University of Kentucky as Professor of Surgery
View Bio
Roger Vertrees, Ph.D.CHIEF SCIENCE OFFICERRoger is a Certified Clinical Perfusionist Emeritus, and he received his Ph.D. from the University of Texas in Biomedical Sciences with a concentration in Experimental Oncologic Pathology.
View Bio
MITCHEL K. MAY JDCHIEF EXECUTIVE OFFICER
Mitchel K May is a distinguished healthcare leader with over 30 years of experience in operational management, financial strategy, and innovative healthcare solutions.
View Bio
JAN WINETZ, M.D.CHIEF CLINICAL OFFICER
Jan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the Cornell University Medical College, residency and served as a Chief Resident at S.U.N.Y.
GUIDING OUR RESEARCH
Our Board
of Directors
Our board of directors consists of passionate, dedicated individuals with a wealth of experience in the areas of cancer and hyperthermia treatments. We are proud to have a diverse board that provides insight into various aspects of cancer care. They are integral to our mission of providing patients with exceptional treatment.
LOU LANGBOARD MEMBER, CONSULTANTLouis Lang is a former 32-year member and Leader in the Illinois House of Representatives, as well as one of Illinois premier Government Affairs attorneys.
View Bio
MAREK STUBLEYBOARD MEMBER, CONSULTANTMr. Marek Stubley is a Founding Partner at the highly specialized boutique law firm in Prague of A3K. A3K caters to a select group of successful executives and corporate clientile.
View Bio
ROGER VERTREES, PH.D.CHAIRMAN OF THE BOARD, CHIEF SCIENCE & TECHNOLOGY OFFICERRoger is a Certified Clinical Perfusionist Emeritus, and he received his Ph.D. from the University of Texas in Biomedical Sciences with a concentration in Experimental
Oncologic Pathology.
View Bio
JAY SMITHBOARD MEMBER, SECRETARYJay was a certified public accountant with a large national firm and has over 30 years of
experience as a financial executive.
View Bio
PETRA SMELTZER STARKEBOARD MEMBERPetra Smelter Starke is the founder and CEO of a global growing hot yoga healthy
lifestyle brand SweatNGlow.
View Bio
JAN WINETZ, M.D.CHIEF CLINICAL OFFICERJan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the Cornell University Medical College with a residency, and then he served as a Chief Resident at S.U.N.Y.
View Bio
Paul J ManafortBOARD MEMBER, CONSULTANTPaul J Manafort is a political consultant and government affairs professional whose career spanning five decades has been devoted to furthering the interests of United States.
View Bio
CANCER SPECIALISTS
Our Medical
Advisory Board
Combining cutting-edge technology with evidence-based treatment, the medical advisory board at Verthermia includes top minds of cancer treatment. Our team is composed of experienced specialists and scientists who are committed to helping our patients achieve positive outcomes. Collectively, they bring a wealth of knowledge and experience to the table, allowing us to stay ahead of emerging trends in hyperthermia cancer treatment.
DENNIS CHI, M.DONCOLOGISTDr. Chi has been an attending surgeon at Memorial Sloan Kettering Cancer Center for
more than 25 years.
View Bio
JAMES CUSACK, M.DGASTROINTESTINAL SURGEON, COLORECTAL SURGEONDr. Cusack serves on the Harvard Medical School faculty, Massachusetts General staff,
and the consulting staff at Dana-Farber Cancer Institute.
View Bio
ROBERT DEBERNARDO, M.D.ASSOCIATE PROFESSOR, ONCOLOGY SPECIALISTDr. DeBernardo is a Cleveland Clinic Gynecologic Oncologist and is also the Director of
Minimally Invasive Surgery in Cleveland Clinic’s Ob/Gyn & Women’s Health Institute
View Bio
DANIEL LABOW, M.D.SURGICAL ONCOLOGISTDr. Labow is the Executive Vice Chair of the Department of Surgery at Mount Sinai. He iS additionally the Vice Chair of Quality for the Department of Surgery
View Bio
JOSEPH ZWISCHENBERGER, M.D.CHIEF MEDICAL OFFICER, GYNECOLOGIC ONCOLOGISTDr. Zwischenberger serves at the University of Kentucky, Professor of Surgery and
Pediatrics,
View Bio
DAVID BARTLETT, M.D.CHAIR OF THE AHN CANCER INSTITUTE, ALLEGHENY HEALTH NETWORKDr. Bartlett is the Chair of the Allegheny Health Network Cancer Institute. Prior to that, he served as the Vice Chairman of Surgical Oncology
View Bio
Clinical Trial Results
At Verthermia®, we believe that everyone should have access to effective cancer treatments and strive to provide our clients with the best care possible.
Ovarian
Cancer Trial
Our ovarian cancer trial resulted in significant findings on the positive impacts of HEATT®. Patients overall experienced improved survival rates and daily living satisfaction.
Lung
Cancer Trial
Verthermia® trial patients with unresponsive lung cancer exceeded average life expectancy after receiving HEATT®.
Contact Us
Today
The system and methods of Verthermia® are protected by four issued US patents (11,065,379; 11,185,622; 11,191,883, and 11,239,551). Two other US patent applications are in process, and one international or PCT (Patent Cooperation Treaty) application is in process. Verthermia® has two registered US trademarks, and two other US trademark applications are in process.
Contact Us
Frequently Asked Questions
Yes, HEATT therapy has been shown to be both safe and effective, as demonstrated in our FDA-approved clinical trial without comment or reservation!
What can be effectively treated with HEATT®?
HEATT® can be used to treat all kinds of cancers as well as various other diseases. Please reach out to our team of medical experts and we will discuss if HEATT® is right for you.
What is the recovery time for HEATT®?
Most patients stay in the hospital for about 3-4 days, depending on individual recovery needs. Post-treatment care takes place in the recovery room at First Baptist Medical Center and is included as part of the process.
Can HEATT therapy treat Lyme disease?
Research from 2017 indicates that the Lyme disease bacteria, Borrelia burgdorferi, struggles at elevated temperatures—becoming immobile at 102.2°F, losing structural integrity at 104°F, and being fully eradicated at 106.9°F for two hours. HEATT therapy safely reaches 107.6°F and, when combined with antibiotics, offers a comprehensive approach to tackling the bacteria.
What is the difference between whole-body hyperthermia and localized or regional hyperthermia?
Whole-body hyperthermia, as used in HEATT therapy, raises the body’s temperature to a therapeutic level, making it suitable for systemic conditions. Localized or regional hyperthermia, on the other hand, targets heat to a specific tumor or area, focusing only on the isolated cancer/Tumor sites. Localized and regional methods don’t address cancers spread to the bloodstream, nor can they safely reach an internal temperature of 42°C (107.6°F). HEATT therapy, validated by our FDA-approved clinical trials, is the only whole-body hyperthermia treatment proven to achieve this temperature safely and effectively across the entire body.
Where is HEATT therapy administered?
Treatments are performed in the operating room at First Baptist Medical Center in Dallas, Texas. We regularly care for patients from across the U.S. and beyond, offering a reliable setting for your treatment.
The frequency of HEATT® treatments depends on the individual heat treatment for cancer designed by our medical team.
Who conducts the HEATT® procedure?
Our team of experienced medical professionals conducts the HEATT® procedure, ensuring the highest standards of care, safety, and affordable hyperthermia cancer treatment cost.
How do I prepare for my hyperthermia cancer treatment?
Preparation involves a thorough medical evaluation and consultation with our specialists to tailor the treatment to your needs.
Is HEATT® an FDA-approved treatment?
Yes, HEATT® uses all FDA-approved devices and follows strict safety protocols. FDA-Approval came without comment or reservation.
Which types of cancer does HEATT therapy treat?
HEATT therapy is designed to address all cancers. To confirm if it’s the right option for your specific case, we recommend consulting with our medical team, who are here to guide you with expertise and care.